Theravance Biopharma, Inc.
NasdaqGM:TBPH
$ 9.12
$0.00 (0.00%)
$ 9.12
$0.00 (0.00%)
End-of-day quote: 04/27/2024

TBPH - Theravance Biopharma Stock Prediction 2025 - 2030

10 years of reliable Theravance Biopharma stock forecast. The Wall Street analysts predict Outperform for TBPH. See at a glance whether NasdaqGM:TBPH will rise in the future.

$0.00
Forecast 2023
$10.60
Forecast 2025
$16.59
Forecast 2030
Underperform
TopGraphs Quality Ranking
Forecast 2023
$0.00
Forecast 2025
$10.60
Forecast 2030
$16.59
TopGraphs Quality Ranking
Underperform

Company Info

P/E
0.00
Beta
0.35
Price-to-book Ratio
2.06
Market Cap
0.45B
TEV
0.40 B
Dividend
$0.00
Div Yld
0.00%
Forecast 1Y
0.00%
Forecast 2Y
0.00%
Analyst Price Target
$14.50

Theravance Biopharma Price Chart

1M 3M YTD 1Y 2Y 5Y 10Y 20Y

Theravance Biopharma Stock Forecast 2023

$15.00

In the last five quarters, Theravance Biopharma’s Price Target has risen from $9.95 to $14.50 - a 45.73% increase. Three analysts predict that Theravance Biopharma’s share price will increase in the coming year, reaching $15.00. This would represent an increase of 3.45%.

64.47%
64.47
Last update: 04/27/2024

Highest Price Target $21.00

Average Price Target $15.00

Lowest Price Target $10.00

Theravance Biopharma Stock Forecast 2025

Stock Prediction for the Price of One Theravance Biopharma Share in Jan 2025.

In Jan 2025 analysts predict a share price of $9.77. An increase of 7.14% compared to today's share price.

Stock Prediction for the Price of One Theravance Biopharma Share in Feb 2025.

In Feb 2025 analysts predict a share price of $9.85. An increase of 7.97% compared to today's share price.

Stock Prediction for the Price of One Theravance Biopharma Share in Mar 2025.

In Mar 2025 analysts predict a share price of $9.92. An increase of 8.8% compared to today's share price.

Stock Prediction for the Price of One Theravance Biopharma Share in Apr 2025.

In Apr 2025 analysts predict a share price of $10.00. An increase of 9.63% compared to today's share price.

Stock Prediction for the Price of One Theravance Biopharma Share in May 2025.

In May 2025 analysts predict a share price of $10.07. An increase of 10.46% compared to today's share price.

Stock Prediction for the Price of One Theravance Biopharma Share in Jun 2025.

In Jun 2025 analysts predict a share price of $10.15. An increase of 11.29% compared to today's share price.

Stock Prediction for the Price of One Theravance Biopharma Share in Jul 2025.

In Jul 2025 analysts predict a share price of $10.23. An increase of 12.12% compared to today's share price.

Stock Prediction for the Price of One Theravance Biopharma Share in Aug 2025.

In Aug 2025 analysts predict a share price of $10.30. An increase of 12.95% compared to today's share price.

Stock Prediction for the Price of One Theravance Biopharma Share in Sep 2025.

In Sep 2025 analysts predict a share price of $10.38. An increase of 13.78% compared to today's share price.

Stock Prediction for the Price of One Theravance Biopharma Share in Oct 2025.

In Oct 2025 analysts predict a share price of $10.45. An increase of 14.61% compared to today's share price.

Stock Prediction for the Price of One Theravance Biopharma Share in Nov 2025.

In Nov 2025 analysts predict a share price of $10.53. An increase of 15.44% compared to today's share price.

Stock Prediction for the Price of One Theravance Biopharma Share in Dec 2025.

In Dec 2025 analysts predict a share price of $10.60. An increase of 16.26% compared to today's share price.

Theravance Biopharma Stock Predictions 2030

Theravance Biopharma Stock Predictions for Jan 2030.

In January 2030 analysts predict a stock price of $15.28. An increase of 67.59% compared to the previous month's estimate.

Theravance Biopharma Stock Predictions for Feb 2030.

In February 2030 analysts predict a stock price of $15.40. An increase of 68.89% compared to the previous month's estimate.

Theravance Biopharma Stock Predictions for Mar 2030.

In March 2030 analysts predict a stock price of $15.52. An increase of 70.19% compared to the previous month's estimate.

Theravance Biopharma Stock Predictions for Apr 2030.

In April 2030 analysts predict a stock price of $15.64. An increase of 71.48% compared to the previous month's estimate.

Theravance Biopharma Stock Predictions for May 2030.

In May 2030 analysts predict a stock price of $15.76. An increase of 72.78% compared to the previous month's estimate.

Theravance Biopharma Stock Predictions for Jun 2030.

In June 2030 analysts predict a stock price of $15.88. An increase of 74.08% compared to the previous month's estimate.

Theravance Biopharma Stock Predictions for Jul 2030.

In July 2030 analysts predict a stock price of $15.99. An increase of 75.38% compared to the previous month's estimate.

Theravance Biopharma Stock Predictions for Aug 2030.

In August 2030 analysts predict a stock price of $16.11. An increase of 76.67% compared to the previous month's estimate.

Theravance Biopharma Stock Predictions for Sep 2030.

In September 2030 analysts predict a stock price of $16.23. An increase of 77.97% compared to the previous month's estimate.

Theravance Biopharma Stock Predictions for Oct 2030.

In October 2030 analysts predict a stock price of $16.35. An increase of 79.27% compared to the previous month's estimate.

Theravance Biopharma Stock Predictions for Nov 2030.

In November 2030 analysts predict a stock price of $16.47. An increase of 80.56% compared to the previous month's estimate.

Theravance Biopharma Stock Predictions for Dec 2030.

In December 2030 analysts predict a stock price of $16.59. An increase of 81.86% compared to the previous month's estimate.

P/E
0.00
Beta
0.35
Price-to-book Ratio
2.06
Market Cap
0.45B
TEV
0.40 B
Dividend
$0.00
Div Yld
0.00%
Forecast 1Y
0.00%
Forecast 2Y
0.00%
Analyst Price Target
$14.50

Theravance Biopharma Analyst Ratings Frequently Asked Questions

Who are the analysts watching Theravance Biopharma, Inc.?

The following analysts have recently covered Theravance Biopharma:

Evercore ISI
H.C. Wainwright & Co.
Leerink Partners LLC
Marktfeld
TD Cowen
BTIG
(This information refers to the last 90 days.)

Who are the sell-side analysts watching Theravance Biopharma, Inc.?

The following sell-side analysts have recently covered Theravance Biopharma:

Bayko, Liisa Ann
Tsao, Douglas Dylan
Risinger, David Reed
Paraskevopoulos, Michail
Frahm, Marc Alan
Harrison, Julian Reed
(This information refers to the last 90 days.)